CANF
Can-Fite BioPharma
CANF
CANF
11 hedge funds and large institutions have $1.87M invested in Can-Fite BioPharma in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
|
$488K |
2 |
2
Morgan Stanley
New York
|
$247K |
3 |
VF
3
Virtu Financial
New York
|
$35K |
4 |
TSS
4
Two Sigma Securities
New York
|
$17K |